Le Lézard
Classified in: Health
Subject: SVY

Indonesia Healthcare Market on the Basis of Revenue is Expected to Reach USD 32 Billion by 2022: Ken Research


GURUGRAM, India, March 15, 2018 /PRNewswire/ --

Indonesia healthcare market has shown a positive growth during 2012-2017 at a CAGR of 10.0% but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017.

     (Logo: http://photos.prnewswire.com/prnh/20130909/638322 )

Increase in private hospitals contributed significantly in the growth of hospital market due to rise in specialized medical services and increased spending on healthcare. For instance, number of mother and child hospitals has increased from 169 in 2012 to 178 in 2015. Major hospitals in Indonesia are PT Mitra Keluarga Karyasehat Tbk, Sarana Meditama, Siloam Hospitals and PT Sejahteraraya Anugrahjaya

Indonesia Pharmaceutical market revenue has grown at a CAGR of 11.7% in the last 5 years. The market is primarily driven by government's economic and healthcare initiatives with respect to FDI regulations which have facilitated foreign investment in this space. Anti-infective drug has the largest share in Indonesia Pharmaceutical industry revenue in 2017. This is mainly due to high prevalence of bacterial, viral and communicable diseases. Bayer AG, Kalbe Farma Tbk PT, Tempo Scan Pacific Tbk PT, Sido Muncul PT, Darya-Varia Group are the leading players in Indonesia Vitamin and Dietary Supplements market in 2017.

The advanced medical devices are imported from countries such as Germany, US, China, Japan and Singapore. The import value for medical devices has doubled itself in last 2 years. Local companies majorly deal in surgical gloves, bandages, hospital hollowwares and other equipments. The diagnostic imaging devices have accounted for the largest proportion of the total demand in 2017 driven by the growing awareness among people about early disease diagnosis and a high number of ongoing research activities. X-ray segment has dominated the market which is a cost effective diagnostic technique. Diagnostic imaging techniques - ultrasound is the most frequently used procedure, followed by X-ray, CT, MRI, and nuclear medicine.

The major private laboratory chains have expanded their operations in terms of capacity and geographic presence. The largest private laboratory chain, Prodia established 9 new labs during 2012 to 2017. Prodia's number of clinical laboratory increased from 120 in 2012 to 129 in 2017. Precision medicine is an emerging approach for disease treatment and prevention that takes into account an individual's genetic history, environment and lifestyle during treatment. Precision medicine can be successfully implemented with the availability of diagnostic information, such as individual gene sequencing.

A major factor behind the rising number of pharmacies is the growth of prescription sales driven by an aging population and a range of new drugs. Independent pharmacies have also added value with specialty services. This includes free home delivery, after sale services for medical equipment and medication synchronization and counseling, especially for more complex drugs like the biologics.

According to the report by Ken Research titled "Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment", rising investment by foreign players in the country would increase the demand for medical devices and other associated products in the newly developed infrastructure, hence boosting the overall market.

Key Topics Covered in the Report: 



For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/general-healthcare/indonesia-healthcare-market/143541-91.html

Related Reports by Ken Research 

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region

Indonesia Clinical Laboratory Market Outlook to 2022 - By Type (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), By Type of Test (Routine, Non Laboratory and Esoteric)

Indonesia Pharmacy Retail Market Outlook to 2022 - by Pharmacies & Drugstores and By Region (Central Java, East Java, West Java, North Sumatra, Jakarta and Others)

Indonesia Medical Devices Market Outlook to 2022 - By Medical Consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices, By Imports & Domestic Production

Indonesia Hospital Market Outlook to 2022 - By Public & Private Hospital, By General & Specialty Hospital, By Region

Contact Us:
Ken Research
Ankur Gupta
Head Marketing
[email protected]
+91-1244230204 ext. 28


These press releases may also interest you

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...



News published on and distributed by: